Skip to main content

Breadcrumb

  1. Home

Highly Prevalent Conditions

Asthma Admission Rate (PDI 14)

  • Admissions with a principal diagnosis of asthma per 100,000 population, ages 2 through 17 years. Excludes cases with a diagnosis code for cystic fibrosis and anomalies of the respiratory system, obstetric admissions, and transfers from other institutions.

    [NOTE: The software provides the rate per population. However, common practice reports the measure as per 100,000 population. The user must multiply the rate obtained from the software by 100,000 to report admissions per 100,000 population.]

    CBE ID
    0728

Asthma in Younger Adults Admission Rate (PQI 15)

  • Admissions for a principal diagnosis of asthma per 100,000 population, ages 18 to 39 years. Excludes admissions with an indication of cystic fibrosis or anomalies of the respiratory system, obstetric admissions, and transfers from other institutions.

    CBE ID
    0283

Asthma Medication Ratio

  • The percentage of patients 5–64 years of age who were identified as having persistent asthma and had a ratio of controller medications to total asthma medications of 0.50 or greater during the measurement year.

    CBE ID
    1800

Asthma: Pharmacologic Therapy for Persistent Asthma

  • Percentage of patients aged 5 years and older with a diagnosis of persistent asthma who were prescribed long-term control medication

    Three rates are reported for this measure:
    1. Patients prescribed inhaled corticosteroids (ICS) as their long term control medication
    2. Patients prescribed other alternative long term control medications (non-ICS)
    3. Total patients prescribed long-term control medication

    CBE ID
    0047

Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy

  • Percentage of patients aged 18 years and older with a diagnosis of nonvalvular atrial fibrillation (AF) or atrial flutter whose assessment of the specified thromboembolic risk factors indicate one or more high-risk factors or more than one moderate risk factor, as determined by CHADS2 risk stratification, who are prescribed warfarin OR another oral anticoagulant drug that is FDA approved for the prevention of thromboembolism

    CBE ID
    1525

Average change in functional status following lumbar spine fusion surgery

  • For patients age 18 and older undergoing lumbar spine fusion surgery, the average change from pre-operative functional status to one year (nine to fifteen months) post-operative functional status using the Oswestry Disability Index (ODI version 2.1a) patient reported outcome tool.

    CBE ID
    2643

Beta Blockade at Discharge

  • Percent of patients aged 18 years and older undergoing isolated CABG who were discharged on beta blockers

    CBE ID
    0117

Bilateral Cardiac Catheterization Rate (IQI 25)

  • Bilateral cardiac catheterization discharges per 1,000 heart catheterizations discharges for coronary artery disease for patients ages 18 years and older. Excludes valid indications for right- side catheterization discharges and obstetric discharges.

    [NOTE: The software provides the rate per hospital discharge. However, common practice reports the measure as per 1,000 discharges. The user must multiply the rate obtained from the software by 1,000 to report specific procedure discharges per 1,000 hospital discharges.]

    CBE ID
    0355